Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A in Axillary Hyperhidrosis
NCT00168402Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2002
- Primary completion
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of onabotulinumtoxinA in axillary hyperhidrosis, sponsored by Allergan. Started Feb 2002; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on NCT00168402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168402.